Court axes rule that let insurers not count copay assistance toward patient costs

A federal district court Monday ruled against a Trump-era exchange policy that allowed insurers to refuse to count the full value of drug manufacturer co-pay coupons toward beneficiaries’ maximum out-of-pocket costs and has remanded the rule to HHS. Patient advocates who backed the suit cheered the decision and called on CMS to immediately issue…